Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Losartan to Reverse Sickle Nephropathy

This study has been completed.
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati Identifier:
First received: November 16, 2011
Last updated: February 1, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)